Navigation Links
Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
Date:5/22/2008

WOODCLIFF LAKE, N.J., May 22 /PRNewswire-FirstCall/ -- In an address to shareholders at the company's annual meeting, Medco Health Solutions, Inc. (NYSE: MHS) Chairman and CEO David B. Snow Jr. today underscored the accelerating momentum of key strategic drivers designed to deliver strong continuing earnings growth through 2008 and beyond -- initiatives ranging from generics, mail-order and specialty pharmacy to retaining and winning customers, and advanced clinical innovation.

"Without question, and by every measure, 2007 represented a breakthrough year for Medco and its shareholders as we surpassed every goal we had established across our business. We achieved a series of records in 2007, including record generic dispensing rate of 59.7 percent, and record mail-order dispensing volume of 94.8 million prescriptions," Snow said. "And we're off to a tremendous start in 2008, setting new sales records since becoming a public company, with $5.1 billion in annualized newnamed sales, $4.6 billion in net-new sales, and a 98 percent client retention rate. On top of all this, we are well underway in transforming the practice of pharmacy," Snow said.

"We are very proud of our 2007 and 2008 results. Our 2009 selling season is already off to a very strong start and we currently expect 2009 to represent another strong year for net-new sales. We look forward to sharing the details of our sales progress during our second quarter earnings call," reported Snow.

Medco Named "Most Admired"

Fortune magazine surveyed 622 companies across 64 industry sectors to compile its list of 'America's Most Admired' Companies, and Medco was named the single-most admired company in the category of Healthcare: Pharmacy and Other Services. In ran
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference
2. Medco Issues $1.5 Billion of Senior Notes
3. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
4. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
5. Medco to Webcast Annual Analyst Day Conference
6. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
7. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
8. Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
9. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
10. Immunosyn Corporation Announces 2007 Results, Files 10KSB
11. NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... PARK, N.C. , Aug. 27, 2015 /PRNewswire/ ... the decision by FedEx, UPS and The US ... certain biological specimens classified as ,select agents, by ... long history of handling these sensitive shipments. ... of global transportation regulations, trained and certified personnel ...
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... ... is increasing its investment in the development and manufacture of highly valued cardiac ... The company’s scientific team's extensive expertise with protein chemistry has led to the ...
(Date:8/26/2015)... China Cord Blood Corporation (NYSE: CO ... provider of cord blood collection, laboratory testing, hematopoietic stem ... that the Company has been informed that Magnum Opus ... by Mr. Yuen Kam, chairman of the board of ... (the "Shares") of  Excellent China Healthcare Investment Limited ("KKR ...
(Date:8/25/2015)... --  WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, and ... Stock Code: 0950), a research-based biopharmaceutical company headquartered in ... of operations in China , today ... whereby WuXi,s Laboratory Testing Division (LTD) will be the ...
Breaking Biology Technology:Marken Ensures Safe Transportation Of Select Agents And Toxins 2Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
... In research and industrial work it is quite often ... protease activity. Using commercially available kits e.g. from Molecular Probes ... from PerkinElmer Life Sciences, VICTOR. , ... from Wallac that can measure fluorescent, photometric and luminescent labels ...
... quantum dots (QDs) have potential applications, ... and sources of laser light. For example, ... herein to possess a nonlinear change in their photoluminescence spectra, ... as monitored by the versatile, ...
... , ... The SPEX FLUOROLOG spectrofluoro-meter, with ... The standard FLUOROLOG configuration has an R928P photomultiplier tube ... For near-IR fluores-cence measurements, an optional solid-state de-tector (DSS-IGA020L) can be ...
Cached Biology Technology:Fluorescence assay for determination of protease activity 2Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 2Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 3Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 4
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... around the world are breathing a sigh of ... of being harvested for their natural disease-fighting substances. ... which lives symbiotically inside the sea squirt, actually ... day be used in cancer treatment. , Despite ...
... F. Eberl and his colleagues at Duke University have uncovered ... shed light on deafness in humans. Their research paper, "Myosin ... Lead to Deafness in Drosophila," is scheduled for publication in ... Eberl says their recent work -- showing that loss of ...
... can be fused with large, protein-based drugs such as ... compound that is capable of surviving the journey through ... over into the bloodstream to be used by the ... California School of Pharmacy. , This technology may allow ...
Cached Biology News:UI researcher studies deafness in fruit flies, humans 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3